Showing recent highlights
What's New
PubMed · December 1, 2026
Researchers found that a balance-focused cardiac rehabilitation program — which combines posture and balance training with heart-healthy exercise — helped more people with coronary artery disease (a condition where the heart's arteries become narrowed) and type 2 diabetes improve their blood sugar level (A1C) and physical fitness compared to standard aerobic exercise alone. Specifically, about 48% of people in the balance-focused program showed meaningful improvements in blood sugar control, versus about 33% in the standard aerobic group — and fitness gains were also notably higher. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that for people who've had coronary artery bypass surgery — a major open-heart operation to improve blood flow to the heart — doing a cardiac rehabilitation exercise program at home appears to be just as effective as attending a center-based program when it comes to improving physical fitness. One interesting finding was that home-based rehab may also help reduce anxiety compared to receiving usual care alone, though the results on anxiety and depression varied quite a bit across the studies, making it hard to draw firm conclusions. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
A study found that among people with coronary artery disease — a condition where the arteries supplying the heart become narrowed — who also had obstructive sleep apnea (a sleep disorder where breathing repeatedly stops and starts), using a CPAP machine (a device worn during sleep to keep airways open) was linked to a meaningful drop in a blood marker tied to blood vessel irritation and inflammation, which can contribute to heart problems. This matters because ongoing inflammation in blood vessels is thought to help drive the progression of heart disease, so finding that CPAP may calm that process is an encouraging sign. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that older adults with coronary artery disease — a condition where the arteries supplying the heart become narrowed — who drank nitrate-rich beetroot juice twice a day for two weeks showed meaningful improvements in how well their blood vessels expanded and relaxed, compared to those who drank a placebo juice with the nitrate removed. Healthy blood vessel flexibility matters because stiff or poorly functioning vessels can raise the risk of serious heart problems like heart attacks or strokes. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that in people with coronary artery disease — a condition where the heart's blood vessels become narrowed or blocked — not all blockages behave the same way. Some people have one concentrated, localized narrowing (called focal disease), while others have a more widespread buildup throughout the vessels (diffuse disease), and some have both. The study found that people with both types combined had the highest overall plaque burden (the total amount of fatty buildup in their arteries), and that the type of disease pattern strongly influenced whether someone ended up having a procedure to open or bypass a blocked artery. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
A study found that for people with coronary artery disease (a condition where the arteries supplying the heart become narrowed), lifting lighter weights for more repetitions until muscles are fully tired puts about the same amount of stress on the heart as lifting heavier weights the traditional way — based on measures like heart rate and blood pressure during exercise. This could matter because lighter-weight exercise might feel more approachable or be easier on the joints for some people, while still giving the heart a similar workout. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that evolocumab, an injectable cholesterol-lowering medication that works differently from statins, helped lower 'bad' LDL cholesterol by about 58 points on average in people who already had heart disease. Across nine studies involving more than 67,000 patients, those taking evolocumab were also significantly less likely to experience serious heart problems like heart attacks or strokes, and less likely to need procedures to reopen blocked heart arteries. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that people with overweight or obesity who had higher blood levels of erythritol — a sugar alcohol often used as a sweetener — also tended to have a higher estimated risk of serious heart problems like heart attacks or strokes. The study also found that when people's erythritol levels dropped over time (through a weight-loss diet), their heart risk estimates and certain harmful fat levels in their blood improved as well. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 27, 2026
A study found that people with heavy calcium buildup in their heart arteries — a condition that raises the risk of serious heart problems like heart attacks or strokes — who took a combination of vitamin K and vitamin D daily for two years saw their calcium buildup grow more slowly compared to those who took a placebo (a dummy pill with no active ingredients). Specifically, the calcium score increased by about 196 units in the supplement group versus 248 units in the placebo group, suggesting the vitamins may help slow this process down. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient should consider taking vitamin K and vitamin D supplements together to help slow down the buildup of calcium in the heart arteries.
What's New
PubMed · October 26, 2026
Researchers found that a new laser-powered device designed to break up calcium deposits inside clogged heart arteries worked safely and effectively in a large group of patients. Hard calcium buildup in arteries — think of it like internal rust that makes the artery walls stiff and difficult to treat — is one of the trickier problems doctors face when placing a stent (a tiny mesh tube used to prop open a blocked artery). In this study, over 93% of patients had a successful procedure and were free from serious heart problems like heart attacks or strokes within 30 days. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 22, 2026
Researchers found that two types of special drug-coated balloons used to open blocked heart arteries — one coated with sirolimus and one coated with paclitaxel (both are medicines that help keep arteries open) — worked about equally well overall for people with coronary artery disease, which is a condition where the arteries supplying the heart become narrowed. However, the paclitaxel-coated balloon did show some advantages in preventing the treated artery from narrowing again in spots that hadn't been treated before. This is early research and hasn't yet changed treatment guidelines.
What's New
NEJM · October 21, 2026
Researchers found that blocking a protein in the blood called Factor XIa — which helps blood clot — may reduce serious heart problems like heart attacks or strokes in people who have recently had a cardiac emergency, without significantly raising the risk of dangerous bleeding. This is a big deal because current blood-thinning treatments do help prevent clots, but they also come with a real risk of serious bleeding, so finding something that might offer protection with fewer bleeding risks would be a meaningful step forward for people with coronary artery disease (a condition where the arteries supplying the heart become narrowed or blocked). This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 15, 2026
Researchers found that for people who had a procedure to open blocked heart arteries (called a stent procedure), stopping aspirin early — within 1 to 3 months — while continuing just one other blood-thinning medication may reduce serious bleeding compared to taking two blood thinners for the full 12 months, without raising the risk of serious heart problems like heart attacks or strokes. The study pooled data from over 31,000 patients across nine separate studies, which gives the findings more weight than a single study alone. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient might be a candidate for stopping aspirin after a few months while continuing the other blood thinner medication, since recent research suggests this could lower bleeding risk without increasing heart problems.
What's New
NEJM · October 14, 2026
Researchers found that people with blockages in multiple heart arteries — a condition called coronary artery disease, where arteries that supply the heart become narrowed — may benefit from taking two blood-thinning medications together for a longer period of time than currently typical. This combination approach, called dual antiplatelet therapy, works by making blood less likely to clot, which could lower the chances of serious heart problems like heart attacks or strokes. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 12, 2026
A study found that for people having a severe type of heart attack — where a main artery is completely blocked — who also have blockages in other heart arteries, fixing all the blockages in a single procedure may actually carry a higher risk of death within one year compared to fixing the additional blockages in a separate procedure later on. This matters because doctors often have to decide in the moment how much to treat, and this finding suggests that a more cautious, step-by-step approach might be safer. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 8, 2026
Researchers found that combining a newer cholesterol-lowering injection called a PCSK9 inhibitor with a standard statin (a common cholesterol pill) may help people who have had an acute ischemic stroke — the kind caused by a blood clot blocking blood flow to the brain. Compared to taking a statin alone, the combination appeared to more than double the odds of regaining independence and significantly cut the chances of having another stroke. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 5, 2026
A study found that for people with coronary artery disease (narrowed or blocked heart arteries) who also have a high risk of bleeding, using a special drug-coated balloon during a procedure to open blocked arteries may lead to fewer serious heart problems like heart attacks or strokes and less major bleeding compared to the standard approach of placing a small metal mesh tube (called a stent) that releases medication. This matters because patients at high bleeding risk often face difficult tradeoffs — the very blood-thinning medicines that protect the heart can also cause dangerous bleeding — so a treatment that may reduce both risks at once is worth paying attention to. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that people with both coronary artery disease (a condition where the heart's blood vessels become narrowed) and sleep apnea who used CPAP therapy — a machine that keeps airways open during sleep — were more likely to see improvements in early signs of a type of heart weakening called heart failure with preserved function. Specifically, about 39% of CPAP users showed improvement after 12 months, compared to only 20% of those who didn't use CPAP. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that patients who had a heart attack and then took Naoxintong — a capsule made from a blend of traditional Chinese herbal ingredients — were significantly less likely to develop heart failure or experience serious heart problems like heart attacks or strokes over the following year, compared to patients who took a placebo (a dummy pill with no active ingredients). Specifically, about 6% of people taking Naoxintong developed heart failure, compared to about 14% in the placebo group — meaning roughly half as many people in the Naoxintong group were affected. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that tirzepatide — a diabetes medication like Ozempic or Victoza but with a dual mechanism — may lower the chances of serious heart problems like heart attacks or strokes by roughly 28% compared to a placebo (an inactive treatment) in people with type 2 diabetes who already have heart disease risk. To reach this finding, researchers combined data from two large studies to estimate what would have happened if patients had taken no active medication instead of a comparison drug. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that people who received daily, hands-on physical therapy sessions right after a heart attack — including guided movement, education, and gradually increasing activity — experienced less decline in their overall quality of life and showed greater emotional well-being compared to those who received standard care alone. Coronary artery disease, which means a buildup of plaque that narrows the heart's arteries, often leads to heart attacks, so understanding how to support recovery afterward matters a great deal for this group. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that a special heart imaging scan called a CT coronary angiogram — which takes detailed pictures of the arteries that supply blood to the heart — can be done with less radiation and less contrast dye (the liquid injected to make blood vessels show up clearly) without losing picture quality, which matters because less contrast dye means less stress on the kidneys. This could be good news for people with coronary artery disease (a condition where the heart's arteries become narrowed or blocked), since they often need these scans regularly and reducing radiation and kidney risk over time is important. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that using artificial intelligence (AI) to analyze CT scans of the heart's arteries — the blood vessels that supply the heart muscle — may help doctors more accurately identify which blockages are serious enough to actually reduce blood flow to the heart. This matters for people with coronary artery disease (a condition where those arteries become narrowed or blocked) because better detection could help doctors decide who truly needs further treatment, without requiring more invasive procedures. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that when doctors used special internal imaging tools — cameras or ultrasound devices threaded into the heart's arteries — to guide a procedure called coronary stenting (where a small tube is placed to open a blocked artery), patients had significantly fewer serious heart problems like heart attacks or strokes compared to those whose procedure was guided by standard X-ray imaging alone. The benefit appeared especially strong for people with more complex blockages and in studies conducted in Asian populations, though researchers aren't yet sure exactly which patients gain the most. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that robotic-assisted heart bypass surgery — where surgeons use robotic arms instead of opening the chest in the traditional way — produced results similar to conventional bypass surgery when it came to key outcomes like how well the new blood vessel connections held up, death rates, and the need for follow-up procedures. The study also compared findings from human researchers to those generated by several popular AI tools, exploring whether AI could reliably summarize medical evidence on this topic. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that for people with a serious blockage in the main artery supplying the heart — called 'left main disease' — open-heart bypass surgery appeared more likely to lower the risk of death and heart attacks compared to a less invasive procedure that opens arteries using a small tube and balloon (called a stent procedure), though the stent procedure was linked to a lower chance of stroke. The difference in death rates between the two approaches was relatively small in some calculations, but across multiple ways of looking at the data, bypass surgery consistently came out ahead on most outcomes. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that for people with coronary artery disease (a condition where the heart's blood vessels become narrowed or blocked) who have multiple problem areas in those vessels, treating all the blocked areas — not just the most urgent one — was linked to fewer serious heart problems like heart attacks or strokes. Two approaches to deciding which areas to treat both showed benefits compared to treating only the single most critical blockage. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that colchicine — an anti-inflammatory medication commonly used for gout — may help reduce serious heart problems like heart attacks or strokes in stroke survivors who also have atherosclerosis (a buildup of fatty deposits in the arteries that can restrict blood flow). Researchers saw fewer serious heart events in the group taking colchicine compared to those receiving usual care alone, though the difference was not large enough to be considered statistically definitive, meaning it could have been due to chance. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether colchicine might help prevent another stroke in the patient if the patient has atherosclerosis, based on recent research about anti-inflammatory medications.
Guidelines
PubMed · October 1, 2026
According to the American Society of Nephrology (ASN) guidelines, people with chronic kidney disease — a condition where the kidneys are gradually losing their ability to filter waste from the blood — face a much higher risk of serious heart problems like heart attacks or strokes, heart failure, and early death, which is why regular heart health screening is strongly recommended for this group. The ASN highlights that newer medications, including a diabetes medication like Jardiance or Invokana and a diabetes medication like Ozempic or Victoza, have shown meaningful benefits for both heart and kidney health in these patients. These guidelines emphasize that heart disease, kidney disease, and metabolic conditions like diabetes are deeply connected and need to be treated together rather than separately.
Ask your doctor: Ask the doctor whether the patient should be screened more often or in different ways for heart disease since the patient has kidney disease, and what medications might help protect both the heart and kidneys at the same time.
What's New
PubMed · October 1, 2026
Researchers found that a newer type of heart imaging scan using a radioactive tracer called flurpiridaz was better at detecting coronary artery disease — a condition where the arteries supplying the heart become narrowed — compared to the older standard scan. The newer scan was especially more accurate in women and in people with obesity, and it also delivered a lower radiation dose while producing clearer images. This is early research and hasn't yet changed treatment guidelines.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.